HEMELINCKX MAZOUT financials
A multi-period view of the public annual-account figures reported for HEMELINCKX MAZOUT, with comparable measures and links to available source documents.
Company overviewRegistry number
0808635649
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 27, 2026
Financial evidence
Latest movements for HEMELINCKX MAZOUT
2025 versus 2024
- Operating line
- €328,709
- EBITDA
- €319,502
- Total assets
- €3,885,897
- Equity
- €656,499
+97.1%
+41%
-3.3%
+38.5%
EBITDA margin +97.2% · Equity ratio +16.9%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202530 Sept 2025 | €328,709 | €319,502 | €3,885,897 | €656,499 | - |
| 202430 Sept 2024 | €166,788 | €226,588 | €4,018,940 | €473,991 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.